Hospital health care cost of diarrheal disease in Northern Ghana.
Diarrhea caused by rotaviruses is one of the most frequent causes of hospitalization among pediatric patients in rural communities of developing countries in sub-Saharan Africa and Southeast Asia, and it is a major cause of death in these communities. The complexity of diarrhea and the increasing cost of treatment puts additional burden on the health sector. To demonstrate the economic burden of diarrhea to policy makers, this study was conducted to estimate the treatment cost of diarrhea in children <5 years old in Ghana using the World Health Organization protocol for cost data collection and estimation. The study was undertaken in Navrongo War Memorial Hospital in northern Ghana. Cost estimates were made for 3 treatment scenarios observed: (1) treatment by rehydration, (2) treatment by rehydration and antibiotics, and (3) treatment of diarrhea and other diseases. The average outpatient treatment costs for the 3 treatment scenarios were US$3.86, $4.10, and $4.35 respectively, and the average treatment costs for hospitalization (inpatient care) were $65.14, $97.40, and $133.86 respectively. The annual national treatment costs, based on the 3 treatment scenarios, ranged from $907,116 to $1,851,280 for outpatients clinic visits and from $701,833 to $4,581,213 for hospitalizations. The average length of stay for the inpatients ranged from 2.3 to 4.9 days. The study did not cover patient costs (ie, household costs).
Aikins
Moses
M
University of Ghana, Legon, Ghana.
Armah
George
G
Akazili
James
J
Hodgson
Abraham
A
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D003967:Diarrhea / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D005869:Ghana / Q000453:epidemiology; D017721:Hospital Costs / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015532:Rehydration Solutions / Q000191:economics / Q000627:therapeutic use; D012400:Rotavirus Infections / Q000191:economics / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D015532:Rehydration Solutions